Susquehanna International Group
BDTX icon

Susquehanna International Group’s Black Diamond Therapeutics BDTX Stock Holding History

Susquehanna International Group’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.3K Buy
26,900
+15,600
+138% +$37.1K ﹤0.01% 12600
2025
Q4 		$27.5K Sell
11,300
-57,400
-84% -$203K ﹤0.01% 11895
2025
Q3 		$260K Buy
+68,700
New +$201K ﹤0.01% 10439
2025
Q2 		– Sell
-23,000
Closed -$35.6K – 12655
2025
Q1 		$35.6K Buy
+23,000
New +$48.2K ﹤0.01% 11966
2024
Q4 		– Sell
-192,800
Closed -$839K – 12180
2024
Q3 		$839K Buy
192,800
+181,600
+1,621% +$988K ﹤0.01% 7224
2024
Q2 		$52.2K Sell
11,200
-10,700
-49% -$57.4K ﹤0.01% 11396
2024
Q1 		$111K Buy
21,900
+10,000
+84% +$40.3K ﹤0.01% 11149
2023
Q4 		$33.4K Sell
11,900
-134,600
-92% -$316K ﹤0.01% 11850
2023
Q3 		$420K Sell
146,500
-34,000
-19% -$125K ﹤0.01% 8634
2023
Q2 		$912K Buy
180,500
+165,000
+1,065% +$337K ﹤0.01% 6897
2023
Q1 		$29.3K Buy
+15,500
New +$35.6K ﹤0.01% 11922
2022
Q4 		– Sell
-88,000
Closed -$149K – 12405
2022
Q3 		$149K Buy
88,000
+41,700
+90% +$129K ﹤0.01% 11240
2022
Q2 		$114K Buy
+46,300
New +$108K ﹤0.01% 11344
2022
Q1 		– Sell
-15,000
Closed -$80K – 12970
2021
Q4 		$80K Sell
15,000
-2,600
-15% -$18.2K ﹤0.01% 12280
2021
Q3 		$149K Sell
17,600
-15,500
-47% -$153K ﹤0.01% 11791
2021
Q2 		$403K Sell
33,100
-16,200
-33% -$320K ﹤0.01% 10111
2021
Q1 		$1.2M Buy
+49,300
New +$1.33M ﹤0.01% 7245

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Susquehanna International Group's BDTX Position: Q1 2026 in Review

Susquehanna International Group reduced its Black Diamond Therapeutics (BDTX) stake by 25% in Q1 2026, selling an estimated $61.5K and leaving 78,858 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #11877.

Susquehanna International Group first reported a position in BDTX in Q4 2020 and has held it in 20 quarters since. The position peaked at $2.15M in Q1 2024. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

  • Susquehanna International Group held 78,858 shares of Black Diamond Therapeutics worth $168K as of Q1 2026.
  • Susquehanna International Group sold 25,866 Black Diamond Therapeutics shares in Q1 2026, an estimated $61.5K.
  • Black Diamond Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11877 holding.
  • Susquehanna International Group first reported a position in Black Diamond Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • Susquehanna International Group's Black Diamond Therapeutics position peaked at $2.15M in Q1 2024.
  • 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.